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Abstract
Human mesenchymal stem cells (hMSC) are easily isolated from the bone marrow by adherence to plastic surfaces. These
cells show self-renewal capacity and multipotency. A unique feature of hMSC is their capacity to survive without serum.
Under this condition hMSC neither proliferate nor differentiate but maintain their biological properties unaffected.
Therefore, this should be a perfect platform to study the biological effects of defined molecules on these human stem cells.
We show that hMSC treated for five days with retinoic acid (RA) in the absence of serum undergo several transcriptional
changes causing an inhibition of ERK related pathways. We found that RA induces the loss of hMSC properties such as
differentiation potential to either osteoblasts or adipocytes. We also found that RA inhibits cell cycle progression in the
presence of proliferating signals such as epidermal growth factor (EGF) combined with basic fibroblast growth factor (bFGF).
In the same manner, RA showed to cause a reduction in cell adhesion and cell migration. In contrast to these results, the
addition of EGF+bFGF to serum free cultures was enough to upregulate ERK activity and induce hMSC proliferation and cell
migration. Furthermore, the addition of these factors to differentiation specific media instead of serum was enough to
induce either osteogenesis or adipogenesis. Altogether, our results show that hMSC’s ability to survive without serum
enables the identification of signaling factors and pathways that are involved in their stem cell biological characteristics
without possible serum interferences.
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Introduction
Human mesenchymal stem cells (hMSC) are isolated from bone
marrow samples by using their property to adhere onto a plastic
surface [1]. These cells show self-renewal capacity and multi-
potency [2] characterized by their ability to differentiate to
chondrocytes, osteoblasts and adipocytes [3]. The small numbers
of these cells in the bone marrow niche [4] makes necessary
expanding this stem cell population for therapeutic purposes.
An important characteristic of hMSC is their capability to
survive at low densities in the absence of serum [5]. We found that
BMP pathway is involved in survival of these cells under these
conditions. We also found that, under such serum free conditions,
these cells maintain their surface markers profile, their ability to
differentiate to mesodermal fates and their ability to proliferate
upon serum re-addition to the medium [6]. This rare property of
hMSC would allow culturing them in a serum free medium
supplemented with growth factors for their expansion or
differentiation in the absence of serum. In addition, this culturing
approach would allow us studying the effects of specific molecules
on cellular processes without interference from serum components.
T h em o l e c u l ec h o s e nt op r o v et h i sp r i n c i p l ew a sR e t i n o i ca c i d
(RA), which is known by its ability to induce many cellular changes in
diverse cell types in vivo and in vitro [7–11]. RA is the oxidized form of
Vitamin A that determines anterior/posterior patterning in chordates
at early developmental stages [12]. RA acts activating specific gene
transcription by binding to heterodimers of the RA receptor (RAR)
and the retinoid X receptor (RXR), which then bind to RA response
elements (RAREs) in regulatory regions of targets genes [13]. Other
two signaling factors used in this study are epidermal growth factor
(EGF) and basic fibroblast growth factor (bFGF), which are known to
promote cell proliferation and differentiation in diverse kind of cells
and tissues via Erk activation [14–19]. Here we describe the effects of
RA on hMSC biological characteristics under serum free conditions
by analyzing the changes at the transcriptome level and verifying such
changes at the cell phenotype level. These changes cause downreg-
ulation of Erk pathways. Opposite results to those of RA were
obtained with EGF and bFGF treatments supporting the role of Erk
regulation in the maintenance of hMSC biological properties.
Results
Transcriptional effect of RA treatment on hMSC
Using the ability of these cells to survive and maintain their
basic properties under serum free conditions as mentioned above,
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12689we investigated the effects of retinoic acid (RA) on hMSC biology
under such conditions. Since RA is known by its ability to induce
major changes in the cell transcriptome, we performed micro-
array experiments using the Affymetrix GeneChip Human Gene
1.0 ST oligonucleotide arrays of cDNA produced from hMSC
cultured for 5 days in 0.5 mMR Ai nD M E Mo ri nD M E Mw i t h
or without 10%FBS. The concentration of RA and the exposure
time to such molecule were chosen according to preliminary
experiments that showed morphological effects induced by the
selected conditions (data not shown). This may suggest that some
transcriptional changes may have occurred under such condi-
tions. The microarrays results showed that from the total of
transcriptional changes (up or down regulated genes) detected in
DMEM or RA compared with 10%FBS, a number of genes were
selectively downregulated or up-regulated by RA treatment (168
upregulated, 247 downregulated) indicating RA specific tran-
scriptional regulation in these cells (Figure 1A). To search for the
biological meaning of these effects we clustered the RA
specifically regulated transcripts (i.e. those changed only by RA
treatment and found unchanged in DMEM alone) by using the
Ingenuity software (Ingenuity Systems). The resulting network
with the best score contained gene transcripts of extracellular
proteins involved in cell migration, cell adhesion, and in hMSC
differentiation to mesodermal fates, sharing direct or indirect
activation of Erk, that were down regulated by RA (Figure 1B).
More in detail, adhesion and migration genes down-regulated by
RA included ALCAM, CD44, LAMA1, POSTN, ITGA7,
ITGA3, TNC, LOX and CSPG4. Differentiation transcripts
down-regulated by RA were: POSTN, CSPG4, TGFB1, NRG1,
LTBP1, COL4A1, TNC, NOTCH3, JAG1, and INHBA. Some
other differentiation related transcripts like HGF, LIFR, and
DUSP5 were up-regulated by RA. Moreover, this Erk centralized
network also shows some proliferation related transcripts that
were down-regulated by RA such as: MAPK6, INHBA, CSPG4,
TGB1, CAV1, YWHAE, and CDC2. Altogether, this network
analysis suggests the possibility that the RA effects on hMSC that
affect diverse cellular properties of hMSC are mediated by ERK
dependent pathways.
RA and EGF+bFGF differently modulate Erk activation
To challenge this hypothesis we started by confirming the effects
of RA on the Erk pathway as suggested by the microarray analysis.
We tested Erk activation in the presence and absence of RA and
under known Erk activating conditions on hMSC. To this end we
made protein lysates from cells cultured for 5 days in DMEM, in
10% FBS or in 20 ng/ml EGF+ 5 ng/ml bFGF with or without
0.5 mM RA. Western blot analysis was performed using antibodies
against human phosphorylated Erk1/2 and against total Erk1
protein. b-actin was used for normalization in densitometry
analysis. The results from these experiments are shown in
Figure 2A–B. The presence of EGF+bFGF increases Erk1/2
phosphorylation while RA blocks this inducing effect whereas the
expression of total Erk1 remains unaffected. Under serum
presence Erk1/2 phosphorylation is moderately induced (com-
pared to EGF+bFGF effect) and the RA inhibitory effect, which is
clearly visualized in DMEM with or without EGF+bFGF, is
undetectable. This suggests that Erk activation under serum is
modulated probably by a mix of positive and negative factors
while EGF+bFGF or RA in DMEM elicit Erk activation or
inhibition in a direct manner respectively. These results demon-
strate that hMSC cultured under serum free conditions provide a
platform to specifically characterize a signaling pathway in these
cells.
RA and EGF+bFGF have opposite effects on hMSC
proliferation
Having established the effects of RA and EGF+bFGF on Erk
activation we wanted to evaluate their effects on hMSC
proliferation. To this end, we analyzed the cell cycle by FACS
analysis of hMSC cultured for 5 days in DMEM alone or in
combination with 20 ng/ml EGF+ 5 ng/ml bFGF and with or
without 0.5 mM RA. Figure 2C–H shows that RA decreases cell
cycle progression by increasing the proportion of cells in G0/G1
while in contrast EGF and bFGF combination promotes cell cycle
progression synergistically. These opposite effects between RA and
EGF+bFGF are consistent with their opposite effects on Erk
activation as shown above. At the next step we wanted to know
whether this antiproliferative RA effect is reversible. To this end
we performed similar FACS analysis on hMSC cultured for two
days either in DMEM or in 0.5 mM RA in DMEM followed by
further two days culture in 20 ng/ml EGF+ 5 ng/ml bFGF in
DMEM after thorough washes. Figure 2I–J indicates that the
blocking effect of RA on hMSC proliferation is maintained even if
RA is removed before EGF+bFGF treatment. This suggests that
the transcriptional changes of proliferation genes induced by RA
on hMSC as described in Figure 1 may have irreversible impact
on the proliferative capacity of these stem cells.
Effects of RA, EGF+bFGF and laminin coating on hMSC
adhesion and cell migration
Following the microarray results, the Laminin alpha 1 (LAMA1)
transcript which is down-regulated by RA, and connected to the
ERK pathway (see Figure 1B), was chosen for validating the RA
effects given its known relation with cell migration and adhesion
[20]. In these experiments we validated the effects of RA on
LAMA1 transcription levels by QRT-PCR analysis of cDNA
samples prepared from RNA obtained from hMSC treated for 5
days in the presence or absence of RA. In parallel, following the
EGF+bFGF effects on Erk activation and cell proliferation in the
presence or absence of 0.5 mM RA (see Figure 2) we performed
QRT-PCR analysis of LAMA1 expression in hMSC treated for 5
days with 20 ng/ml EGF+ 5 ng/ml bFGF combination or with
10% FBS, both in the presence and in the absence of RA.
Figure 3A shows the results from these experiments. These results
confirmed the microarray results reflecting that RA causes a
significant decrease in LAMA1 expression. In a similar way as
shown for Erk activation (Figure 2) we observed that EGF+bFGF
treated cells increased LAMA1 expression while together with RA
this effect was blocked. Similarly as shown above for Erk
activation, 10%FBS did not affect significantly LAMA1 expression
compared to DMEM alone but in the presence of RA the
expression of LAMA1 decreased significantly. To study whether
these treatments affect cell migration in hMSC we performed
wound healing assays. To this end we cultured hMSC for 5 days in
DMEM alone or with the addition of 20 ng/ml EGF+ 5 ng/ml
bFGF or 10%FBS in the presence or absence of 0.5 mM RA. After
this period a wound on the different treated cultures was made
mechanically and the closure of the gap by the migrating cells was
followed for seven hours by photographing the area every hour
under an inverted microscope. Figure 3B shows the analysis from
this experiment at the end time point (7 hs) indicating that
whereas EGF+bFGF or FBS promote cell migration, cells in RA
or DMEM are not able to migrate significantly. RA dramatically
reduces the positive effect of EGF+bFGF and of FBS on cell
migration. Moreover, even 5 days pre-treatment with RA before
EGF+bFGF (preRA+EGF+bFGF) at the time of the wound
healing experiment is able to reduce the migration of hMSC.
hMSC in Serum Free Conditions
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EGF+bFGF have an opposite effect on LAMA1 expression that
could be reflected by their respective effects on cell migration. To
investigate whether LAMA1 is required for hMSC migration
we performed a wound healing experiment as described above
but this time hMSC were cultured on either a laminin coated
Figure 1. Microarray bioinformatical analysis of the RA effects on hMSC cultured for 5 days without serum. A: Venn diagram showing
the number of differentially expressed transcripts in DMEM and RA treated hMSC when compared to 10%FBS treated cells. B: The genes regulated
specifically by RA (i.e. blue or yellow in the diagram depicted in A) were clustered by Ingenuity software. This software contains a database with
different transcripts arranged in networks according to their known biological interactions. According to the number of transcripts regulated in each
of these networks, the program scores them. The best scored network is depicted here. Direct interactions are represented by continuous arrows and
direct by dotted ones. Increase in expression is represented by red color and decrease by green. The number under each transcript name is the
logarithmic change in comparison to 10%FBS control cells RNA. The type of interaction is indicated by a label and the type of molecule is indicated by
the shape of the box, being both detailed at the right of the figure.
doi:10.1371/journal.pone.0012689.g001
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described above (see Figure 3A). The results from these experiments
are shown in Figure 3C demonstrating an increase in cell migration
which closes the gap faster when the cells are cultured in a laminin-
coated plate for all the treatments, suggesting that laminin is
required for hMSC migration. Moreover, laminin can rescue the
inhibitory effect of RA on cell migration strongly suggesting that
laminin elicits intracellular signaling pathways that drive cell
migration overriding the negative RA effect. Altogether, these
results strongly supports that the RA effect on laminin downreg-
ulation directly affects hMSC migration capacity.
As mentioned before, laminin is also involved in cell adhesion
[20]. For this reason, we were interested to assess the laminin role
in hMSC adhesion and whether this process is affected by RA.
To this end, we carried out spreading assays after culturing
hMSC in different media treatments for 5 days in a similar way as
stated above (see Figure 3A). We harvested each of the treated
cells using trypsin, and cultured them for 30 minutes in
suspension with the same medium to allow cell matrix protein
recovery. Then, we plated the cells in suspension onto an
uncoated plate or onto a laminin-coated one (20 mg/well), and
then the cells were photographed under an inverted microscope
in order to analyze their perimeter after 4 hours with the aid of
image analysis software. The results from these experiments
(shown in Figure 3D) indicate that serum, but not EGF+bFGF, is
required for hMSC spreading, whereas RA decreases this cell
adhesion process. In addition, laminin is enough by itself to
induce hMSC spreading enhancing cell adhesion, even in the
absence of serum and in the presence of RA. Again, here we
demonstrate that the RA effect on Laminin expression directly
affects hMSC adhesion properties.
Effects of RA, EGF+bFGF and Periostin on hMSC
osteogenesis
So far we have shown that RA affects all the hMSC biological
characteristics we have tested and that the EGF+bFGF combina-
tion promotes most of them. Therefore, we wanted to investigate
Figure 2. RA and EGF+bFGF effects on Erk phosphorylation and on cell cycle progression. A: Western blot analysis of hMSC that were
cultured for 5 days in either DMEM alone (DMEM) or in the presence of 0.5 mM RA (RA) or in the presence of 20 ng/ml EGF+ 5 ng/ml bFGF
(EGF+bFGF), with or without the addition of 0.5 mM RA (EGF+bFGF+RA). As control, cells were cultured with 10%FBS (FBS), or with 0.5 mMR Ai n
10%FBS (FBS+RA). Whole-cell protein extracts from these differently treated cells were fractionated on a denaturating 12% polyacrylamide gel,
transferred to nitrocellulose and detected with anti phosphorylated Erk antibody (pErk1/2). The membrane was stripped twice, one for detection with
anti total Erk antibody (Erk1) and the second for b-actin antibody detection used as loading control. B: Densitometry analysis of A. The bars represent
relative expression normalized to b-actin expression and referred to this ratio in DMEM. C–J: Cell cycle progression by FACS of hMSC that were
cultured for 5 days with DMEM (C), 0.5 mM RA in DMEM (D), 20 ng/ml EGF (E), 5 ng/ml bFGF (F), 5 ng/ml bFGF +20 ng/ml EGF (G), or 5 ng/ml bFGF
+20 ng/ml EGF +0.5 mM RA (H). In addition, hMSC were cultured for 2 days in DMEM (I) or in the presence of 0.5 mM RA (J) before replacement of the
medium with 20 ng/ml EGF +5 ng/ml bFGF in DMEM for further 2 days. At the end of the experiment the cells were harvested by trypsinization,
permeabilized and stained with propidium iodide to measure the DNA content by FACS.
doi:10.1371/journal.pone.0012689.g002
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differentiation could be affected by these factors too. To this end,
hMSC were cultured in osteoblasts differentiation medium for
21 days in the presence or absence of 10% FBS or supplemented
with 20 ng/ml EGF +5 ng/ml bFGF instead FBS, with or with-
out 0.5 mM RA. DMEM supplemented with 20 ng/ml EGF
+5 ng/ml bFGF served as a control to test if these factors alone
promote osteogenesis. To visualize osteoblast differentiation the
cultures were stained with alizarin red at the end of the
experiments. The results from these experiments are shown in
Figure 4 and show that RA blocks osteogenesis induced either by
serum or by EGF+bFGF combination. Interestingly, here we show
for the first time that EGF+bFGF combination replaces the use of
serum in the osteogenesis protocol when the other factors of the
osteogenic medium (dexamethasone, vitamin C and b-glycerol
phosphate) are present.
Microarray analysis results of hMSC (see Figure 1) suggested
Periostin (POSTN) as a possible downregulated target of RA.
Periostin is believed to be involved in the mineralization of the
extracellular matrix that takes place during osteogenesis [21].
Therefore, it was important to validate this result, and at the same
time, since POSTN is known to be upregulated by Erk, to verify
whether EGF+bFGF and even serum are able to increase its
expression. To this end, we performed QRT-PCR analyses with
cDNA obtained from RNA purified from cells obtained from
different donors cultured 5 days in either DMEM, 0.5 mM RA,
20 ng/ml EGF+ 5 ng/ml bFGF, EGF+bFGF+RA, FBS, or
FBS+RA. The results from these experiments are shown in
Figure 5A and indicate that indeed periostin expression is down-
regulated by RA and up-regulated by EGF+bFGF or by serum.
Moreover, RA brings down its expression even in cells treated with
EGF+bFGF or serum. These results confirm the microarray
Figure 3. RA and EGF+bFGF treatments affect laminin expression which modulates cell migration and adhesion of hMSC. A: QRT-PCR
analysis of laminin alpha 1 expression in hMSC that were treated for 5 days with either DMEM, 0.5 mM RA in DMEM (RA), 20 ng/ml EGF+ 5 ng/ml bFGF
(EGF+bFGF), 20 ng/ml EGF +5 ng/ml bFGF +0.5 mM RA (EGF+bFGF+RA), 10%FBS (FBS), or 0.5 mM RA in 10%FBS (FBS+RA). The error bars represent
relative expression normalized to RNF10 expression and referred to the relative expression on DMEM as mean 6 s.e.m. B: Wound healing experiments
were performed on hMSC that were previously treated for 5 days as in A and also treated with 0.5 mM RA followed by EGF+bFGF at the time of the
experiment (preRA+EGF+bFGF). The error bars represent % of the initial gap after 7 hours as mean 6 s.e.m. C: Similar wound healing experiments as
shown in B but hMSC were previously seeded over either laminin coated (20 mg/well) (laminin) or uncoated plates (plastic) and treated as in A. The
error bars represent % of the initial gap after 7 hours as mean 6 s.e.m. D: Cell spreading assay of hMSC that were treated for 5 days similarly as in A
(see Materials and Methods). The error bars represent cell perimeter as mean 6 s.e.m. All the treatments in A–D were performed in triplicates in two
independent experiments with different hMSC donors and the significance of the results was assessed using one way ANOVA and Tukey’s multiple
comparison test (for A and B) or with two way ANOVA followed by Bonferroni post test (for C and D). *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0012689.g003
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importantly they suggest that periostin may be playing a role in
hMSC osteoblast differentiation potential since its expression can
be positively regulated either by EGF+bFGF or by serum.
Following the negative effect observed on the osteogenetic
potential of these cells by RA and the effect on the expression of
periostin induced by this molecule, it was interesting to assess
whether periostin coating could alleviate the negative effect of RA
on osteogenesis of hMSC. For this purpose, we performed
osteoblast differentiation protocol as described above in the
presence of 0.5 mM RA but on uncoated plates or coated either
with 2.5 mg periostin/well or 2.5 mg laminin/well. Laminin
coating was used as matrix specificity control for differentiation.
The results from this experiment are shown on Figure 5B-G and
indicate that indeed periostin is able to rescue hMSC from the
negative effect of RA on their osteogenetic potential whereas
laminin has no effect on it. This demonstrates the need and
specificity of periostin for osteogenesis and that this extracellular
driven signaling pathway overrides RA’s inhibition of differenti-
ation.
Effects of RA and EGF+bFGF on hMSC adipogenesis
Having observed that RA inhibits differentiation of hMSC to
osteoblasts and that EGF+bFGF enhance such process, it was
important to determine if another cell fate potential of hMSC is
affected by these molecules. To this end we performed similar
treatments as shown in Figure 5 using suitable culture media for
adipogenesis. In these experiments we observed, in a similar way
as for osteogenesis, that RA inhibits and EGF+bFGF enhance the
adipogenesis process (see Figure 6).
Discussion
Here we exploit the fact that culturing hMSC under serum free
conditions allows studying the specific effects on these cells of
factor/s added to the medium. This approach gave us the
possibility to investigate the effects of RA on hMSC biological
properties. We found that RA treatment inhibits the transcription
of specific genes that converge in Erk inactivation. This effect is
visualized by a decrease in typical properties of hMSC such as
cell migration, adhesion, proliferation and loss of differentiation
potential to both osteoblasts and adipocytes. In contrast to these
results we found that EGF and bFGF combination strengthens
the mesenchymal properties of these cells promoting cell
migration, proliferation and differentiation of hMSC to such
fates. Microarray analyses suggested that RA down regulated
genes that are biologically related to Erk regulatory pathways
(Figure 1). These results were confirmed by Western blot analysis
showing that after 5 days exposure to RA the phosphorylation of
Erk is decreased. In contrast, EGF+bFGF combination up-
regulates Erk phosphorylation but RA is capable to decrease it
even in the presence of EGF+bFGF (Figure 2A–B). Altogether,
these findings strongly indicate that Erk is regulated by the
extracellular factors RA and EGF+bFGF that elicit opposite
phenotypic effects on the hMSC biological characteristics
mentioned above. To the best of our knowledge this is the first
evidence showing the importance of these signaling factors in
hMSC biology and the implication of the Erk pathways in these
adult stem cell characteristics.
Although we have not deciphered yet the mechanism
responsible for the RA effect on Erk phosphorylation, results
from the microarray experiment supports that RA directly affects
this signaling pathway since several known activators of Erk such
as COL4A1 [22], CD44 [23], CAV1 [22], CSPG4 [24], ITGA3
[25], TGFB1 [26], ALCAM [27], VIM [28], LAMA1 [22] and
TNC [29] were also down-regulated by RA (Figure 1).
Interestingly, RA affects negatively the proliferation capacity of
hMSC which is promoted by either EGF or bFGF or by a
combination of both factors (Figure 2C–H). Pre-incubation with
RA decreases the ability of hMSC to proliferate even in the
presence of EGF+bFGF (Figure 2I–J). This may indicate that RA
causes irreversible changes in the cell transcriptome that influence
also the proliferative capacity even after its removal. Our findings
are in accordance with previous works showing enhancement of
hMSC proliferation by EGF and bFGF [30]. However, this is the
first time that the opposite effects of RA and EGF+bFGF are
shown at the proliferation level in parallel to the Erk activation in a
serum free context.
Figure 4. hMSC osteogenesis is inhibited by RA and enhanced by EGF+bFGF. hMSC were cultured for 21 days in osteoblasts differentiation
medium without serum supplemented with 10% FBS (A), 10% FBS +0.5 mM RA (C), nothing (D), 0.5 mM RA (E), 20 ng/ml EGF +5 ng/ml bFGF (F),
20 ng/ml EGF +5 ng/ml bFGF +0.5 mM RA (G), or were cultured in DMEM supplemented with 10% FBS (B) or with 20 ng/ml EGF +5 ng/ml bFGF (H)
(negative controls). To visualize differentiation osteoblasts were stained with alizarin red after fixation in 70% ethanol. Size bars=100 mm.
doi:10.1371/journal.pone.0012689.g004
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increased by EGF+bFGF. This process is also promoted by serum
and by laminin alone (Figures 3B–C). These findings are in
accordance with the effect of each of these treatments in the
expression of LAMA1 (laminin 1), as shown by QRT-PCR
analysis (Figure 3A) and with our microarray analysis (Figure 1).
Given that laminin rescues the RA effect, this means that possibly
laminin activates some integrin mediated intracellular signals that
may transduce in Erk activation. This is in accordance with a
recent work showing a positive effect of Laminin1 on Erk
activation and on cell spreading in hMSC from bone marrow
under serum free conditions [31].
Pretreatment of hMSC with RA also impairs cell migration
even before the addition of EGF+bFGF (Figure 3B). The fact that
Figure 5. Periostin can rescue the effect of RA on hMSC osteogenesis. A: hMSC were treated for 5 days with either DMEM, 0.5 mMR Ai n
DMEM (RA), 20 ng/ml EGF+ 5 ng/ml bFGF (EGF+FGF), 20 ng/ml EGF +5 ng/ml bFGF +0.5 mM RA (EGF+FGF+RA), 10%FBS (FBS), or 0.5 mMR Ai n
10%FBS (FBS+RA). The RNAs were purified and the cDNAs were synthesized using reverse transcriptase. Periostin transcript was quantified in each
sample. The error bars represent relative expression normalized to RNF10 expression and referred to the relative expression on DMEM as mean 6
s.e.m. All the treatments were performed in triplicates in two independent experiments with cDNA from different donors and the significance of the
results was assessed using one way ANOVA and Tukey’s multiple comparison test. B–G: hMSC were cultured in osteoblasts differentiation medium
supplemented with 0.5 mM RA (B–D), or in 10%FBS +0.5 mM RA (negative control) (E–G), for 21 days over uncoated plastic (B and E), 2.5 mg laminin/
well coated plastic (C and F), or 2.5 mg periostin/well coated plastic (D and G). Osteoblasts were stained with alizarin red. Size bars=100 mm.
doi:10.1371/journal.pone.0012689.g005
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medium supports the view that RA causes transcriptional changes
in the cell that decrease also the potential of hMSC to migrate.
Another typical characteristic of hMSC that has been affected by
RA treatment is cell adhesion. We showed that laminin alone
restores the ability of these cells to adhere (Figure 3D).
Interestingly here, EGF+bFGF did not have an apparent effect
on cell spreading. This in fact strengthens the central role of
laminin to drive cell adhesion in these stem cells which may
activate an independent signal transduction pathway to that of
EGF+bFGF.
We found that RA inhibits osteogenesis. In addition, when we
cultured the cells with differentiation medium but without serum,
the differentiation did not take place. However, when EGF+bFGF
were added to this serum free osteogenic medium it enhanced
notably this differentiation (Figure 4). Our results are in
accordance with other authors [32,33] claiming that Erk activation
enhance osteogenesis in hMSC. However, this is the first report of
a totally serum free osteogenesis protocol that could be developed
for therapeutic purposes in the future.
We found that periostin expression is decreased by RA
according to our microarrays (Figure 1). QRT-PCR confirmed
this and also demonstrated that EGF+bFGF increase periostin
expression (Figure 5A). This suggests that periostin may be playing
a role in hMSC osteogenesis since its expression can be positively
regulated either by EGF+bFGF or by serum (which promote
osteogenesis) and down-regulated by RA (which inhibits this
process). Following this, we determined that periostin is able to
rescue the negative effect of RA on osteogenesis when supplied
exogenously (Figure 5B–G). This result demonstrates the need and
specificity of periostin for osteoblast differentiation promotion and
that this extracellular driven signaling pathway overcomes RA’s
inhibition of differentiation. It is important to note that whereas
periostin is able to rescue the RA effect on osteogenesis, laminin is
able to rescue the effect of RA on adhesion but not on
osteogenesis. This is in accordance with the role of each of these
proteins and suggests that laminin can be important to maintain
the stem cell status prior to differentiation whereas periostin seems
to have a role at the end of the differentiation, specifically in the
mineralization process [21].
Studies have shown that mitogen-activated protein kinase
(MAPK) [34,35] and phosphatidylinositol 3-kinase (PI-3K) [36]
activity are critical switches for osteogenic differentiation. In
addition, the study from Seib et al. further demonstrates that
spontaneous osteogenesis in human MSCs is regulated through
these signaling pathways, which can be induced by endogenous
BMPs [37]. These works coincide with our Western blots from
lysates of hMSC treated with EGF+bFGF (Figures 2A–B) which
show that this factor’s combination promotes Erk phosphorylation,
but also up-regulates PI-3K as judged by Akt phosphorylation
(data not shown).
The results showing RA inhibition of adipogenesis and
EGF+bFGF enhancement of this process (see Figure 6) further
support the opposite effects of these molecules on the hMSC
biology. Interestingly, osteogenesis and adipogenesis are equally
affected by these molecules.
It is possible that the loss of hMSC properties like cell survival,
cell adhesion, cell migration, and differentiation to mesodermal
fates induced by RA treatment are also accompanied by a change
in the cell status of hMSC. To verify this possibility we checked in
our microarray analysis the effect of RA in hMSC identity. We
found that 11.5% of the upregulated transcripts are related to
ectodermal lineage while 10.1% of the downregulated transcripts
are from mesodermal origin. This fact certainly suggests that RA is
inducing these cells to a more ectodermal state of differentiation.
This suggestion is in accordance with the known ability of RA to
induce neuroectodermal differentiation [38].
The present study opens the possibility to use bone marrow
hMSC in serum free conditions for therapeutic purposes. Since we
show the principle that the basic properties of these cells do not
change with serum deprivation, it might be possible theoretically
to expand them (using for example EGF+bFGF) and differentiate
Figure 6. hMSC adipogenesis is inhibited by RA and enhanced by EGF+bFGF. hMSC were cultured for 21 days in either adipocytes
maintenance medium (days 7–8 and 15–16) or adipocytes induction medium (the rest of the days) (see Materials and Methods for seeing the media
composition), without serum, supplemented with 10% FBS (A), 10% FBS +0.5 mM RA (C), nothing (D), 0.5 mM RA (E), 20 ng/ml EGF +5 ng/ml bFGF (F),
20 ng/ml EGF +5 ng/ml bFGF +0.5 mM RA (G). In addition, hMSC were cultured in DMEM supplemented with 10% FBS (B) or with 20 ng/ml EGF
+5 ng/ml bFGF (H) (negative controls). To visualize differentiation, adipocytes were stained with Oil red O after fixation with 4% paraformaldehyde.
Size bars=100 mm.
doi:10.1371/journal.pone.0012689.g006
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addition, we show the principle that these cells may serve as a
platform for studying specifically the effects of different molecules
on their cell biology such as RA and/or EGF+bFGF. Therefore,
this study is important for the fields of regenerative medicine and
cell biology.
Materials and Methods
Ethics statement
Samples were obtained from the iliac crest’s bone marrow of
healthy donors (20 to 65 years old) who had signed for written
consent according to the guidelines of the ethics committee of the
Laniado Hospital (supervised by the Israeli Health Ministry) which
specifically approved this study.
hMSC isolation and culture
The bone marrow aspirates were diluted 1:2 with Hanks’
Balance Salt Solution (Biological Industries, Israel). The mononu-
clear cell layer was isolated by density gradient using UNI-SEP
maxi tubes (Novamed, Israel) centrifuged at 1000 g for 20
minutes, and resuspended in 6 volumes of medium (referred from
here onwards as FBS). FBS was composed of DMEM (Gibco,
Invitrogen, NY, USA) supplemented with 1 mM MEM Sodium
Pyruvate (Gibco, Invitrogen, NY, USA), 1% Penicillin-streptomy-
cin-nystatin solution (Biological Industries, Israel), and 10% FBS
(Hyclone, USA). The cells were cultured in polystyrene plastic
75 cm
2 tissue culture flasks (Corning, NY, USA) at 37uC with 5%
CO2. hMSC were isolated by their characteristic plastic adherence
while other cells were washed through successive medium
replacement as previously described [39]. Cell passages were
made when cells reached 80–90% confluency (,1.2610
6 cells/
flask). hMSC from passages 2 to 7 were used for the different
experiments.
Differentiation to osteoblasts
hMSC were plated (60000 cells/well) in 24 wells plates and
grown to confluence. Then the cells were cultured during 14–17
days in a medium (changed every 2–3 days) composed of DMEM
(Gibco, Invitrogen, NY, USA) supplemented with 1 mM MEM
Sodium Pyruvate (Gibco, Invitrogen, NY, USA), 1% Penicillin-
streptomycin-nystatin solution (Biological Industries, Israel),
0.1 mM dexamethasone (Sigma, MO, USA), 0.2 mM ascorbic
acid 2-phosphate (Sigma, MO, USA), and 10 mM glycerol 2-
phosphate (Sigma, MO, USA). The medium was employed with
or without 10% FBS (Hyclone, USA), with or without 0.5 mM RA,
and with or without a combination of 20 ng/ml EGF +5 ng/ml
bFGF. The obtained osteoblasts were fixed in 70% ethanol and
stained with Alizarin Red (Sigma, MO, USA).
Differentiation to adipocytes
hMSC were cultured during 21 days in 24 well plates at 60000
cells/well using the following medium change schedule since
100% confluency was reached: days 1, 3, 5: induction medium;
day 7: maintenance medium; days 9, 11, 13: induction medium;
day 15: maintenance medium; days 17, 19, 21: induction medium.
Maintenance medium was composed of DMEM (Gibco, Invitro-
gen, NY, USA) supplemented with 1 mM MEM Sodium Pyruvate
(Gibco, Invitrogen, NY, USA), 1% Penicillin-streptomycin-nysta-
tin solution (Biological Industries, Israel), 10% heat inactivated
FBS (Hyclone, USA), and 10 mg/ml insulin (Sigma, MO, USA).
Induction medium was composed of maintenance medium
supplemented with 1 mM dexamethasone (Sigma, MO, USA),
0.5 mM IBMX (Sigma, MO, USA), and 100 mM indomethacine
(Sigma, MO, USA). The resulting adipocytes were fixed in 4%
paraformaldehyde and stained with Oil Red O solution (Sigma,
MO, USA).
FACS for cell cycle analysis
Cultured hMSC were collected by trypsinization. The cells were
re-suspended in PBS and transferred to a FACS tube, centrifuged
and re-suspended again in PBS. Then 0.1% triton X-100 and
20 mg/ml PI were added to stain the cell nuclei. The cell cycle
pattern of the PI stained material was analyzed by a FAC-
SORT
TM (Becton Dickinson) flow cytometer using an argon laser
at 488 nm.
Microarray analysis
All experiments were performed using Affymetrix GeneChip
Human Gene 1.0 ST oligonucleotide arrays. 100–600 ng of total
RNA from each sample, purified by TRIzol reagent (Invitrogen,
USA), was used to prepare biotinylated target DNA that was
processed following manufacturer’s recommendation, using an
Affymetrix GeneChip Instrument System. The quality of starting
RNA was confirmed using agarose gel electrophoresis. Ingenuity
IPA software was used to build protein interaction networks
between the differentially regulated genes.
Quantitative Real-Time PCR
QRT-PCR assays were carried out in triplicates on a Rotor-
Gene 6000 real-time rotator analyzer (Corbett Research) using the
Absolute QPCR SYBR green (Thermo Scientific) according to
manufacturer’s instructions. The different pairs of specific primers
(Table 1) were added at a final concentration of 200 nM in a 10 ml
reaction volume mix containing 1.5 ml cDNA. Thermo-cycling
conditions were: 95uC for 15 minutes followed by 45 cycles at
95uC for 10 seconds, 56uC for 15 seconds and 72uC for 20
seconds. At the end of the process a melt analysis step ranging
from 72uCt o9 5 uC was added to assess the specificity of the
reaction. The threshold cycle number (Ct) was determined for all
PCR reactions by automatically adjusting the threshold within the
logarithmic curve, using Rotor-Gene 6000 series software (Corbett
Research). A non-template control was included for each gene. A
concentration vs. Ct curve was build for each gene using known
dilutions from a cDNA mix of all the samples. The relative
concentration of each gene in each sample, calculated by
interpolating its Ct in its respective curve, was normalized to the
relative concentration of RNF10 in the same sample.
Western blot
Cell lysates were obtained with RIPA buffer (Sigma) in the
presence of the ‘‘Complete’’ protease inhibitor (Roche). The
lysates were sonicated, spun down at 9000 g and the protein
concentration was calculated in each supernatant by BCA protein
assay kit (Pierce, IL, USA). A 12% SDS-PAGE was loaded with
11.5 mg protein from each sample after boiling for 10 minutes, and
Table 1. Primers used for QRT-PCR in this study.
Gene Forward 59 to 39 Reverse 59 to 39
LAMA1 CAGGACCCATTACCCTTTTG GCCCTGCTTGGTTTCTTTATT
Periostin CCCTATAAACGCCAACAATCA TCTGTTGAAGGGCACAGACA
RNF10 AAGGGAGGTCACTGGTGTTG CTTCATCGAAGGCAGACAGA
doi:10.1371/journal.pone.0012689.t001
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onto a nitrocellulose membrane. After 1 hr blocking at room
temperature in blocking buffer [5% non fat milk in Tris-buffered
saline/1% tween 20 (TBS/T)] and after washing three times for 5
minutes each in TBS/T, the membranes were incubated
overnight at 4uC with the primary antibody (Table 2) diluted in
5% Bovine serum albumin in TBS/T. Following three washes
with TBS/T, secondary antibody (Table 2) diluted 1:4000 in
blocking buffer was added for 1 hr at room temperature and
washed three times with TBS/T. The detection was performed by
ECL reaction. All the signals were quantified by normalizing to
the b-actin signal.
Wound healing assay
Wound healing experiments were performed on confluent
cultures of hMSC treated for 5 days under different conditons.
Following the treatments a scratch was mechanically made to
produce a gap on the cell layer. The cells were photographed at
the gap area to visualize and measure changes in the gap width
due to cell migration, at the beginning and 7 hours after the
wound was made. The percent of the initial gap after 7 hours was
determined by the ratio between the average widths measured at
several points along the gap in the images from the two time
points.
Cell spreading assay
hMSC were treated for 5 days with different conditions. Then,
the cells were collected by trypsinization and were incubated in
suspension for 30 minutes at 37uC with the same media to allow
them to regenerate adhesion molecules. Then the cells were plated
back on 24 well-plates either uncoated or coated with 20 mg
laminin per well. Following 4 hours of incubation, the cells were
photographed. Cell perimeter was measured for each cell in the
population using Slidebook
TM (Intelligent imaging, Inc.) software
as parameter for assessing cell adhesion under the different culture
conditions tested.
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